Muller & Phipps (Ceylon) PLC

MULL.N0000Overvalued

Consumer & Retail · Wholesale Distributors

Muller & Phipps (Ceylon) PLC is a Sri Lanka-based importer and distributor operating in the healthcare and pharmaceutical sector.

MULL shares are up 5.0% over the past year and last closed at Rs 2.10 on Sep 30, 2026.

Rs 2.10
+0.00%
Price history
+5.00%

Monthly seasonality

Monthly total returns by year and calendar month
YearJanFebMarAprMayJunJulAugSepOctNovDec
2026+14.3-4.2-13.0+15.0-8.7+0.0+0.0+0.0+0.0+0.0+0.0+0.0
2025+27.3-7.1-7.7+0.0+8.3+7.7+21.4+17.6-5.0+26.3-4.2-8.7
2024+10.0-9.1+10.0+9.1+0.0-8.3+0.0-9.1+20.0+0.0-8.3+0.0
2023+0.0+9.1+0.0-8.3-9.1+10.0+9.1+0.0-8.3+0.0+0.0-9.1
2022+0.0-22.7-41.2-20.0+12.5+11.1+10.0+9.1+16.7-14.3-8.3+0.0
2021+27.3-21.4+0.0+0.0+0.0+0.0+9.1+0.0+0.0-8.3+18.2+69.2
2020-20.0+0.0-25.0+0.0+0.0+0.0+14.3+0.0+37.5-9.1+0.0+10.0
2019+14.3-25.0+16.7+0.0-14.3+16.7+14.3-12.5-14.3+50.0+11.1+0.0
2018-9.1+0.0+0.0+0.0-10.0-11.1+0.0+0.0-12.5+0.0+14.3-12.5
2017-8.3-9.1+10.0+0.0+9.1-8.3-9.1+10.0+0.0+9.1-16.7+10.0
2016+0.0+7.7-14.3+8.3+0.0+0.0+0.0+0.0+0.0-7.7+0.0+0.0
2015+0.0-6.7-14.3+25.0-6.7+7.1+0.0-6.7+0.0+0.0-7.1+0.0
2014+18.2+0.0-7.7+8.3+0.0+0.0+0.0+7.7+21.4-5.9-12.5+7.1
2013-5.6-11.8+0.0+6.7+6.3-11.8-13.3-7.7+8.3+0.0-7.7-8.3
2012+0.0+0.0+0.0-10.5-23.5+23.1+0.0+12.5+22.2-18.2-11.1+12.5
Average+4.9-7.2-6.2+2.4-2.6+2.4+3.7+1.4+5.7+1.6-2.3+5.0
ASPI average+3.1-2.7-4.7+2.0+0.2+0.8+3.1+2.2+3.2-0.1+1.0+3.0
Median+0.0-6.9-3.8+0.0+0.0+0.0+0.0+0.0+0.0+0.0-5.7+0.0
% up43%14%21%43%29%40%40%33%40%21%21%36%
P/E
-
P/B
Negative book
EPS
Rs -0.23
Div Yield
0.00%
Market Cap
Rs 594.3M
Beta
3.83
ROE
-
Op Margin
-12.8% (+3.8pp)

Fundamentals

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue
Rs 587.3M
-19.0%
Rs 724.6M
-5.1%
Rs 763.5M
+44.9%
Rs 526.9M
-50.5%
Rs 1.1B
+41.8%
Rs 750.9M
-11.4%
Rs 847.1M
-14.3%
Rs 988.6M
+5.5%
Operating profit
Rs -49.2M
Rs -56.8M
Rs 87.0M
+11.4%
Rs 78.1M
-34.1%
Rs 118.5M
+63.2%
Rs 72.7M
Rs -25.3M
Rs -2.2M
Net profit
Rs -71.4M
loss narrowed
Rs -83.7M
fell into loss
Rs 75.1M
turned profitable
Rs -88.3M
loss widened
Rs -36.7M
fell into loss
Rs 66.8M
turned profitable
Rs -104.0M
loss widened
Rs -60.5M
fell into loss
EPS
-0.25
-0.30
0.27
-0.31
-0.13
0.24
-0.37
-0.21

Compared with the same period a year earlier.

Per-share figures are as reported, not adjusted for splits.

Recent dividends

  • 2018Rs 0.05
  • 2017Rs 0.07
  • 2014Rs 0.05
Sector comparisonConsumer & Retail · 35 companies
Rs 1,788.00
P/E
11.4
P/B
30.98
ROE
272.71%
Yield
8.81%
P/E
14.2
P/B
10.66
ROE
90.67%
Yield
5.68%
Rs 675.00
P/E
16.0
P/B
4.29
ROE
26.90%
Yield
2.74%
Rs 1,858.75
P/E
13.3
P/B
3.40
ROE
26.25%
Yield
2.15%
Rs 118.75
P/E
14.4
P/B
4.99
ROE
34.77%
Yield
5.99%
Rs 76.40
P/E
11.2
P/B
4.15
ROE
37.21%
Yield
2.64%
Rs 2,512.75
P/E
8.6
P/B
2.17
ROE
25.15%
Yield
2.69%
Rs 1,200.00
P/E
48.0
P/B
8.23
ROE
17.14%
Yield
0.00%
MULL.N0000 · this company
Rs 2.10
P/E
-
P/B
-
ROE
-
Yield
0.00%
Sector median · 35 companies
P/E 13.3P/B 1.66Yield 1.72%

About Muller & Phipps (Ceylon) PLC

Muller & Phipps (Ceylon) PLC is a Sri Lanka-based importer and distributor operating in the healthcare and pharmaceutical sector. The Group distributes pharmaceutical and healthcare products through an ERP-enabled, island-wide network supported by 16 distributors and more than 3,000 customer touchpoints. The Company’s activities include pharmaceutical distribution, marketing and medical engagement, and supply chain management, underpinned by compliance-driven operations and digital sales platforms. During the year the Group expanded into therapeutic nutrition with the introduction of Dreavia Switzerland nutrition products, including Dreavia Rontamil. The Group operates in Sri Lanka and comprises Muller & Phipps (Ceylon) PLC and its wholly owned subsidiary, Muller & Phipps (Health Care) Limited, leveraging distribution, professional engagement, and digital channels to service healthcare professionals, retailers and other customers nationwide.

AI analysis

bearish

Muller & Phipps remains loss-making, with June revenue down 12.2% year-on-year and gross margin at its worst of seven comparable Junes. Losses narrowed, but the core recovery is incomplete.

Read the full report (Aug 8, 2026) →

News sentiment

Describes news flow, not a forecast
Last 30 days
Not enough news to read

No scored news in the last 30 days.

24 months positive negative 3-month net
Mar 23Jul 23Nov 23Mar 24Jul 24Nov 24
Recent news
View all news →

Consumer & Retail sector: what is happening

Last 14 days to Sep 30, 2026

Consumer retail faced pressure from accelerating food, transport and housing inflation, with petrol a major contributor to the rise in national prices and purchasing power weakened by higher energy costs and tax hikes. Wholesale and retail activity nevertheless helped drive faster services-sector expansion in August. Specialist retail also consolidated as Blink International acquired Wrist Lab, combining retail, distribution and after-sales networks.

Auto-generated from 8 sector news articles over 14 days. Not investment advice.